Comparison of Three Ovulation Induction Therapies for Patients With Polycystic Ovary Syndrome and Infertility
This article is protected by copyright. All rights reserved.PMID:37493193 | DOI:10.1002/jcph.2318 (Source: The Journal of Clinical Pharmacology)
Source: The Journal of Clinical Pharmacology - July 26, 2023 Category: Drugs & Pharmacology Authors: Ting-Ting Xia Ke-Fei Zeng Qing-Mei Peng Source Type: research
Comparison of Three Ovulation Induction Therapies for Patients With Polycystic Ovary Syndrome and Infertility
This article is protected by copyright. All rights reserved.PMID:37493193 | DOI:10.1002/jcph.2318 (Source: The Journal of Clinical Pharmacology)
Source: The Journal of Clinical Pharmacology - July 26, 2023 Category: Drugs & Pharmacology Authors: Ting-Ting Xia Ke-Fei Zeng Qing-Mei Peng Source Type: research
Pregnancy outcomes from controlled ovarian hyperstimulation in overweight and obese patients without pcos treated with letrozole versus clomiphene citrate
Anovulatory cycles due to gonadotropin dysfunction contribute to infertility in women with polycystic ovary syndrome (PCOS). Women with PCOS have significantly higher luteinizing hormone (LH) pulse amplitude and frequency compared to women without PCOS(1). However, body mass index (BMI) was significantly negatively correlated with LH pulse amplitude in PCOS and non-PCOS women(1). Even in obese ovulatory women, LH secretion was reduced due to impaired LH pulse amplitude (2). However, following treatment with letrozole, mean LH levels and pulse amplitudes were significantly higher compared to no treatment(2, 3). (Source: Fer...
Source: Fertility and Sterility - July 1, 2023 Category: Reproduction Medicine Authors: Xiaohong Liu, Arielle Yeshua, Jerry Wang, Kate Devine, Benjamin S. Harris, Phillip A. Romanski Source Type: research
Clomiphene citrate throughout the duration of ovarian stimulation: an approach to decrease costs, reduce injection burden, and prevent premature ovulation in patients with diminished ovarian reserve
Clomiphene citrate (CC) has been widely utilized as an adjunct in ovarian stimulation protocols for in-vitro fertilization (IVF) to capitalize on pituitary follicle-stimulating hormone (FSH) release in patients with diminished ovarian reserve (DOR). In these protocols, CC is typically administered with gonadotropins for the first five days followed by GnRH antagonist to prevent premature ovulation. However, due to its antiestrogenic mechanism of action at the pituitary, CC may also effectively prevent the LH surge if continued until day of trigger. (Source: Fertility and Sterility)
Source: Fertility and Sterility - July 1, 2023 Category: Reproduction Medicine Authors: Rachel S. Mandelbaum, Samuel Melville, Aaron Masjedi, Intira Sriprasert, Molly M. Quinn, Richard J. Paulson, John G. Wilcox, Joie Z. Guner Source Type: research
Molecules, Vol. 28, Pages 5112: Quercetin and Ferulic Acid Elicit Estrogenic Activities In Vivo and In Silico
This study provides promising insights into the potential use of quercetin as a therapeutic agent for the management of female fertility issues. (Source: Molecules)
Source: Molecules - June 29, 2023 Category: Chemistry Authors: Meryem Slighoua Fatima Ez-Zahra Amrati Mohamed Chebaibi Ismail Mahdi Omkulthom Al Kamaly Khadija El Ouahdani Aziz Drioiche Asmaa Saleh Dalila Bousta Tags: Article Source Type: research
Intrauterine Insemination After Human Chorionic Gonadotropin Trigger or Luteinizing Hormone Surge: A Meta-analysis
CONCLUSION: This meta-analysis showed no difference between pregnancy outcomes between at-home LH monitoring and timed IUI.SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42021230520.PMID:37290111 | DOI:10.1097/AOG.0000000000005222 (Source: Obstetrics and Gynecology)
Source: Obstetrics and Gynecology - June 8, 2023 Category: OBGYN Authors: Nivedita R Potapragada Elnur Babayev Danielle Strom Molly Beestrum Jacob M Schauer Emily S Jungheim Source Type: research
Oral sildenafil citrate: a potential approach for improvement of endometrial thickness and treatment of unexplained infertility in women
CONCLUSIONS: Adding sildenafil citrate to CC is a good choice for overcoming the antiestrogenic action of CC and improving ET in women with unexplained infertility, especially in those with less than 2 years of infertility.PMID:37259740 | DOI:10.26355/eurrev_202305_32465 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - June 1, 2023 Category: Drugs & Pharmacology Authors: R M Sarhan S A M Salem M H Elkomy R M Albuhayran R R S Hussein M S Boshra Source Type: research
Oral sildenafil citrate: a potential approach for improvement of endometrial thickness and treatment of unexplained infertility in women
CONCLUSIONS: Adding sildenafil citrate to CC is a good choice for overcoming the antiestrogenic action of CC and improving ET in women with unexplained infertility, especially in those with less than 2 years of infertility.PMID:37259740 | DOI:10.26355/eurrev_202305_32465 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - June 1, 2023 Category: Drugs & Pharmacology Authors: R M Sarhan S A M Salem M H Elkomy R M Albuhayran R R S Hussein M S Boshra Source Type: research
Oral sildenafil citrate: a potential approach for improvement of endometrial thickness and treatment of unexplained infertility in women
CONCLUSIONS: Adding sildenafil citrate to CC is a good choice for overcoming the antiestrogenic action of CC and improving ET in women with unexplained infertility, especially in those with less than 2 years of infertility.PMID:37259740 | DOI:10.26355/eurrev_202305_32465 (Source: European Review for Medical and Pharmacological Sciences)
Source: European Review for Medical and Pharmacological Sciences - June 1, 2023 Category: Drugs & Pharmacology Authors: R M Sarhan S A M Salem M H Elkomy R M Albuhayran R R S Hussein M S Boshra Source Type: research
